(Original title: The net sales of northbound funds hit the third highest in history this week, and they bought Sungrow and Zijin Mining against the trend)
This week, A-shares fluctuated and declined as a whole under the influence of external stock markets. The Shanghai Composite Index fell by 4%, the Shenzhen Composite Index fell by 4.4%, and the ChiNext Index fell by 3%. There were three trading days this week, and the A-share market staged a “V-shaped” rebound, showing that some funds were underpinning. The industry believes that the current market sentiment is still relatively fragile, and the market may still be dominated by structural repairs in shocks.
From the perspective of the main capital flow, only 7 industries received a net inflow of main capital this week, and the remaining 97 secondary industries of Shenwan were sold by the main force. Among them, the semiconductor, gold, and tourism industries received more major net purchases, all exceeding 300 million yuan, while banking, optical optoelectronics, electronic manufacturing, securities, computer applications, chemicals, rare metals and other industries suffered major net outflows of more than 40 million yuan. billion.
From the perspective of the main capital flow of individual stocks, excluding the secondary new stocks listed since 2021, the main net inflows of individual stocks such as Dayang Bio, Dongbei Group, Qinglong Pipeline Industry, Zhongjia Bochuang, NorthGlass, Xiongdi Technology, Tianbao Infrastructure, and Minovar The proportion is higher. Due to rumors of a special drug for the new crown, the stock price of Ocean Bio has soared recently, rising nearly 30% this week. However, Ocean Biology stated on the investor interactive platform on March 11 that ethyl trifluoroacetate can be used in the production of various pharmaceutical intermediates. As for whether trifluoroacetic acid can be used in Japan’s Shionogi new crown special medicine, it is not yet known.
From the data of the Dragon Tiger List, this week, the total transaction volume of institutional seats was 7.185 billion yuan, of which 2.547 billion yuan was bought and 4.639 billion yuan was sold. The top three stocks bought by institutions are Jiu’an Medical, Huayou Cobalt, and Rongbai Technology, and the top three stocks sold are Rongbai Technology, Rongsheng Petrochemical, and Wanfu Bio. The stock price of Rongbai Technology fell sharply in the first two trading days of this week, and fell by 17.66% on March 8. That day, there were four institutions dedicated to selling the dragon and tiger list, and only one institution dedicated to the buying list, with a total net sales of 415 million yuan. .
Northbound funds have not entered the market since the index V started on the afternoon of March 11, and left the market firmly this week. Both index V-shaped rebounds continued to flow out in the middle of the week. Wind data shows that northbound funds sold a net 5.042 billion yuan throughout the day on Friday, including a net sales of 3.142 billion yuan through Shanghai Stock Connect and 1.9 billion yuan through Shenzhen Stock Connect. Sales hit a new high since March 2020, and net sales ranked third in history.
However, from the perspective of individual stocks, northbound funds did not short all, but selectively increased their positions in certain stocks, such as Sungrow and Zijin Mining. Both stocks received net purchases of more than 1 billion yuan this week. In addition, Guodian NARI, LONGi Co., Ltd., and Yangtze Power are all among the net purchasers of northbound funds.
Reporter Chen Hui